Market Probability

No market

Status

Introduced

Committee

Floor Vote

Other Chamber

Signed

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Rep. Smith, Adrian [R-NE-3](R-NE-3)

2 cosponsors

Summary

Medicare IVIG Access Enhancement Act of 2025

This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)

Subjects

Drug therapyHealth care costs and insuranceHealth care coverage and accessMedicareNeurological disorders

Actions (4)

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Feb 7, 2025House floor actions

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Feb 7, 2025House floor actions

Introduced in House

Feb 7, 2025Library of Congress

Introduced in House

Feb 7, 2025Library of Congress